EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Five-Year Follow-up Study on Safety and Efficacy of Macroplastique® in Female Patients with Stress Urinary Incontinence (the ROSE Study)

Gamal Ghoniem iD, Felicia Lane, Bilal Farhan, Kelli Gilliam, S Abbas Shobeiri, Ahmed Salah

International Urogynecology Journal · 2025

DOI: 10.1007/s00192-025-06163-5 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von Gamal Ghoniem und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of California, Irvine, CA, USA. gghoniem@hs.uci.edu. Hauptthemen laut MEDLINE: Urinary Incontinence, Stress, Hyaluronic Acid. Die Arbeit nennt 11 Literaturangaben. Gefördert von: Laborie Medical Technologies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND HYPOTHESIS: This study presents the 5-year study close-out results from the Real-Time Observation of Safety and Effectiveness (ROSE) study, evaluating the safety and efficacy of the Macroplastique® (MPQ) urethral bulking agent for the treatment of stress urinary incontinence (SUI) in women with intrinsic sphincter deficiency (ISD). METHODS: The ROSE study was an observational prospective study conducted at 22 US centers that enrolled 274 adult women with ISD-confirmed SUI. Participants underwent MPQ treatment with an option for repeat injections. Follow-up assessments were conducted at 3 months and then annually for 5 years, evaluating SUI severity (Stamey grade), Incontinence Quality of Life (I-QoL), and Patient Global Impression of Satisfaction. Safety outcomes included treatment-related adverse events (AEs) and serious adverse events (SAEs). RESULTS: Of 274 enrolled participants, 147 (54%) completed the 5-year follow-up. At 5 years, 47.6% 19 (70/147) of women showed improvement in SUI severity as measured by Stamey grade from 20 baseline after their last injection. I-QoL scores improved significantly, from 45 ± 23.9 to 70.9 ± 21 24.5 (1.1, 100). One device-related SAE of urinary retention (0.4%) resolved within 4 months; no 22 late-onset SAEs were reported. The most common minor treatment-related adverse events were 23 urinary tract infections (30.8%) and transient urinary retentions (7.2%). No late-onset SAEs were 24 reported during the 5-year period. CONCLUSIONS: Macroplastique® demonstrated sustained long-term efficacy and safety in managing SUI owing to 27 ISD. These findings reinforce its role as a minimally invasive treatment option with 28 durable outcomes over 5 years.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Incontinence, StressHyaluronic AcidHumansFemaleMiddle AgedProspective StudiesFollow-Up StudiesTreatment OutcomeAdultQuality of LifeAgedPatient SatisfactionUrethraSeverity of Illness Index

Stichwörter der Autor:innen

Macroplastique®Stress urinary incontinenceUrethral injection

Substanzen

Hyaluronic Acid

Autor:innen und Institutionen

  • University of California, Irvine, CA, USA. gghoniem@hs.uci.edu.
  • University of California, Irvine, CA, USA.
  • University of Texas Medical Branch, Galveston, TX, USA.
  • Inova Health System, Falls Church, VA, USA.
  • Aswan University, Aswan, Egypt.

ORCID-Profile: Gamal Ghoniem

Förderung

  • Laborie Medical Technologies

Zitieren

APA

Ghoniem, G., Lane, F., Farhan, B., Gilliam, K., Shobeiri, S. A., & Salah, A. (2025). Five-Year Follow-up Study on Safety and Efficacy of Macroplastique® in Female Patients with Stress Urinary Incontinence (the ROSE Study). International Urogynecology Journal. https://doi.org/10.1007/s00192-025-06163-5

Vancouver

Ghoniem G, Lane F, Farhan B, Gilliam K, Shobeiri SA, Salah A. Five-Year Follow-up Study on Safety and Efficacy of Macroplastique® in Female Patients with Stress Urinary Incontinence (the ROSE Study). International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06163-5

BibTeX
@article{Ghoniem2025,
  author = {Ghoniem, Gamal and Lane, Felicia and Farhan, Bilal and Gilliam, Kelli and Shobeiri, S Abbas and Salah, Ahmed},
  title = {Five-Year Follow-up Study on Safety and Efficacy of Macroplastique® in Female Patients with Stress Urinary Incontinence (the ROSE Study)},
  journal = {International Urogynecology Journal},
  year = {2025},
  doi = {10.1007/s00192-025-06163-5}
}
Kostenlos starten →